[MO36] Mini-Oral Session 36　Palliative Care / Symptom Management 2

[MO36-1] Phase III study comparing DEX on day 1 to days 1-4 with combined NK₁-RA, PALO, and OLZ in CDDP-based chemotherapy

^○Takeshi Yanagihara¹, Ayako Yokomizo², Takashi Kawaguchi³, Kazuhiro Shimomura⁴, Hirotoshi Iihara⁵, Mistuhiro Sugawara⁶, Marina Mitsui⁷, Hiroshi Ishikawa⁸, Shuichi Nawata⁹, Ayako Tsuboya¹⁰, Keisuke Mishima¹¹, Kei Morikawa¹², Shunsuke Oyamada¹³, Kazunori Honda¹⁴, Hiroko Yukawa¹, Yasushi Ohno¹⁵, Chikatoshi Katada¹⁶, Naoya Hida¹⁷, Takuhiro Yamaguchi¹⁸, Takako Nakajima¹⁹ (1.Department of Medical Oncology, Yokohama Rosai Hospital, 2.Department of Pharmacy, St. Marianna University School of Medicine Hospital, 3.Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, 4.Department of Pharmacy, Aichi Cancer Center Hospital, 5.Department of Pharmacy, Gifu University Hospital, 6.Division of Clinical Pharmacy, Kitasato University School of Pharmacy, 7.Department of Pharmacy, St. Marianna University School of Medicine Yokohama City Seibu Hospital, 8.Department of Pharmacy, Shizuoka Cancer Center, 9.Department of Pharmacy, Showa University Hospital, 10.Department of Pharmacy, Kawasaki Municipal Tama Hospital, 11.Department of Digestive Surgery, Nippon Medical School Musashikosugi Hospital, 12.Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, 13.Department of Biostatistics, JORTC Data Center, 14.Department of Clinical Oncology, Aichi Cancer Center Hospital, 15.Department of Cardiology and Respiratory Medicine, Gifu University Graduate School of Medicine, 16.Department of Gastroenterology, Kitasato University School of Medicine, 17.Department of Pulmonary Medicine. St. Marianna University School of Medicine Yokohama City Seibu Hospital, 18.Biostatistics, Tohoku University Graduate School of Medicine, 19.Department of Early Clinical Development, Graduate School of Medicine, Kyoto University Hospital)